This product of TriFid Research (IA) offers services in the equity future segment. The companies in which recommendations are generated are from the Top 200 stocks of NSE. The risk-reward ratio on the calls generated under this product will be in the range of approx 1:1.5. High volume stocks are picked under this category. In this product, you can expect the return of Rs. 2000-6000 per call on 1 lot. Risk embedded in recommendation will be managed as per the client’s profile. Clients subscribing to this product will not only receive daily timely follow-ups from an assigned executive but will also get frequent updates on Nifty, SGX Nifty, USDINR, Crude Oil and Gold. Customization of the product based upon the client’s risk-taking capacity is our USP.
Suitable For: The product has especially been created for the small traders and hedgers in the market who wants to generate a return to low investment in the futures market and have the moderate risk-taking capacity.
Message from TriFid Research (IA): We believe in delivering very high-quality service to help our Clients achieve their financial goals. And to realize this objective we constantly work on improving our client's investment/investing experience by catering unique, profitable, personalized products and services.
The Medium of Recommendations:
• Calls/Recommendations will be provided through SMS & Messenger Service
• TriFid Research’s Android-Based Mobile App
Sample Recommendation & Follow-Ups:
• RECOMMENDATION: SELL LICHSGFIN FUT BELOW 564.75 FOR THE TARGETS 562.90/561.05/559.20 WITH THE STOP LOSS 567
• FOLLOW UP: KINDLY BOOK PARTIAL PROFIT IN LICHSGFIN FUT SELL CALL, 2ND TARGET ACHIEVED
• Trade-in every recommendation with equal investment and quantity.
• Follow the company’s advice only.
• Always put stop loss in every trade.
• Do not hold on any recommendation without our advice.
• Do not trade on personal phone calls.
• Use trailing stop loss.
• Follow the recommendation as you received them, do not enter in between.
• Avoid averaging down on an investment.